Johnson & Johnson COVID-19 booster shot bolsters immune protection, FDA employees say
A booster of Johnson & Johnson’s COVID-19 vaccine confirmed indicators of considerably bolstering the immune defenses of examine topics, federal well being regulators mentioned Wednesday.
The regulators cautioned, nonetheless, that knowledge was restricted they usually needed to depend on J&J’s personal evaluation for among the examine findings, somewhat than conducting their very own.
The Meals and Drug Administration employees gave their evaluation of the J&J booster knowledge as a part of the company’s evaluate of the corporate’s request for authorization of the second dose.
After authorizing boosters for seniors and sure high-risk individuals who bought the COVID-19 vaccine from Pfizer Inc. and BioNTech SE, the FDA is now contemplating whether or not to clear further doses of the photographs from J&J and Moderna. It’s also weighing whether or not doses may very well be blended amongst totally different vaccines.
The FDA launched its employees evaluation together with different supplies about J&J’s booster request.